ATP11C | ATPase, class VI, type 11C | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP12A | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATP13A1 | ATPase type 13A1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A3 | ATPase type 13A3 | Predicted membrane proteins
| | | | | Expressed in all |
ATP13A4 | ATPase type 13A4 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ATP13A5 | ATPase type 13A5 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP1A4 | ATPase, Na+/K+ transporting, alpha 4 polypeptide | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP8A1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ATP8B2 | ATPase, aminophospholipid transporter, class I, type 8B, member 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATP8B3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATP9A | ATPase, class II, type 9A | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATP9B | ATPase, class II, type 9B | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1D | Calcium channel, voltage-dependent, L type, alpha 1D subunit | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1E | Calcium channel, voltage-dependent, R type, alpha 1E subunit | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
CACNA1F | Calcium channel, voltage-dependent, L type, alpha 1F subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
CACNA1G | Calcium channel, voltage-dependent, T type, alpha 1G subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1H | Calcium channel, voltage-dependent, T type, alpha 1H subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1I | Calcium channel, voltage-dependent, T type, alpha 1I subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1S | Calcium channel, voltage-dependent, L type, alpha 1S subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
CASD1 | CAS1 domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CEPT1 | Choline/ethanolamine phosphotransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHPT1 | Choline phosphotransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CLCN1 | Chloride channel, voltage-sensitive 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLCN2 | Chloride channel, voltage-sensitive 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CLCN3 | Chloride channel, voltage-sensitive 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLCN5 | Chloride channel, voltage-sensitive 5 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CLCN6 | Chloride channel, voltage-sensitive 6 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |